Announcements Trials
Browse Landscape

Phase

Phase NA 24Phase 3 4Phase 1 2Phase EARLY_PHASE1 1

Status

Unknown 2Terminated 1Completed 1

Sponsor Class

OTHER 2NIH 1INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 3

Conditions

Uterine Cervical Dysplasia 2Uterine Cervical Neoplasms 1Papillomavirus Infections 1Cervical Intraepithelial Neoplasia Grade 2/3 1

Interventions

Cisplatin 725Carboplatin 607Paclitaxel 578Cyclophosphamide 516Radiotherapy 511Docetaxel 475Fluorouracil 453Gemcitabine 437Doxorubicin 383Capecitabine 361Dexamethasone 327Oxaliplatin 288pembrolizumab 283Leucovorin 282Bevacizumab 275Etoposide 271Vincristine 270Rituximab 246Prednisone 222Pemetrexed 217Cytarabine 205Drug Therapy 194Trastuzumab 175Irinotecan 172Methotrexate 171Lenalidomide 137Nivolumab 135Filgrastim 135Epirubicin 129Tamoxifen 127

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Colposcopy × Clear all
NCT04794660 2024-03-13

CESTA

International Agency for Research on Cancer

Phase 3 Unknown
1,500 enrolled

Papillomavirus Infections

NCT01131312 2018-11-20

Randomized Clinical Trial on Clinical Management of ASCUS and LSIL (ALTS)

National Institutes of Health Clinical Center (CC)

Phase 3 Completed
5,060 enrolled 10 charts
Gynecologic

Uterine Cervical Dysplasia

NCT03366493 2017-12-08

The Study of Folate Receptor-Mediated Staining Solution (FRDâ„¢) In Cervical Lesion Detection

GY Highland Biotech LLC

Phase 3 Unknown
200 enrolled
Gynecologic

Cervical Intraepithelial Neoplasia Grade 2/3

NCT00529464 2016-05-09

Spectroscopy Versus Standard Care in Cervical Cancer Patients

M.D. Anderson Cancer Center

Phase 3 Terminated
2 enrolled
Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡